(Q28324212)

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

21 June 2022

author name string

L. B. Jeffcott

1

1 reference

Europe PubMed Central

PubMed publication ID

330156

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A330156

21 June 2022

C. M. Colles

2

1 reference

Europe PubMed Central

PubMed publication ID

330156

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A330156

full work available at URL

21 June 2022

language of work or name

English

0 references

publication date

July 1977

0 references

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.2042-3306.1977.tb03997.x

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.2042-3306.1977.tb03997.x/fullpdf

21 June 2022

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Equine Veterinary Journal

21 June 2022

published in

0 references

volume

9

0 references

issue

3

0 references

page(s)

105-10

0 references

cites work

Toxic Effects of Phenylbutazone on the Cat

5

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

(1) A Clinician's Views on the Use and Misuse of Phenylbutazone

21 June 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds

21 June 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Phenylbutazone: short-term versus long-term administration to thoroughbred and standardbred horses

21 June 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Effect of oxyphenylbutazone on surgical wounds of horses

21 June 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog

21 June 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Acute and chronic toxicity of butazolidin

21 June 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Phenylbutazone; further clinical evaluation

21 June 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

(3) Uses and Misuses of Anti-inflammatory Drugs in Racehorses - II

21 June 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Persistence of phenylbutazone in horses producing acid urines

21 June 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Alteration of the response of platelets to surface stimuli by pyrazole compounds

21 June 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Plasma and urine levels of phenylbutazone in the horse

21 June 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Untoward effects of phenylbutazone (butazolidin)-a re-evaluation

21 June 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

Chromosomal studies in patients taking phenylbutazone

21 June 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

A fatal syndrome in a dog following administration of phenylbutazone

21 June 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.2042-3306.1977.TB03997.X

21 June 2022

Identifiers